Connect with us

Press Release

Charles Howenstine DDS on Why Dentistry Should Focus More on Arresting Disease Than Repairing Damage

Published

on

Michigan, USA, 25th March 2026, ZEX PR WIRE — In modern dentistry, many conversations focus on repairing damage. Fillings replace decay, crowns restore broken teeth, and advanced procedures address long-standing oral health issues. While these treatments remain important, some dentists believe the profession should place far greater emphasis on a different concept: arresting disease before it progresses.

Charles Howenstine DDS, a Stevensville, Michigan dentist and practice owner, believes that one of the most important shifts in dental care is recognizing the power of early intervention and preventive strategies designed to arrest dental disease.

“In dentistry, the word ‘arrest’ has a very specific meaning,” says Dr. Howenstine. “When we say a condition is arrested, we mean the disease process has stopped progressing. The damage is no longer actively spreading.”

This concept can apply to several common oral health issues. For example, an arrested caries lesion refers to tooth decay that is visible but no longer actively damaging the tooth. The bacteria responsible for the decay are no longer progressing deeper into the enamel or dentin. Similarly, early gum inflammation can sometimes be managed in ways that arrest the progression toward more severe periodontal disease.

According to Dr. Howenstine, focusing on arresting disease early can significantly change how patients experience dental care.

A Shift From Reaction to Prevention
Dr. Howenstine’s perspective comes from an unusual professional background that includes both finance and dentistry. Raised in Rice Lake, Wisconsin, he graduated from Rice Lake High School in 1999 and earned a Finance degree from Marquette University in 2003. After working at Capstone Investments, he later returned to school through the University of Wisconsin, Milwaukee and completed dental training at the Marquette University School of Dentistry in 2011.

That early experience in finance shaped how he evaluates risk and long-term outcomes.

“In finance, small problems can grow quickly if they aren’t addressed early,” he explains. “Dental disease works in a very similar way. If you can arrest the issue early, you prevent much larger consequences later.”

Following graduation from dental school, Dr. Howenstine practiced in Wisconsin with Midwest Dental in Kimberly before relocating to Stevensville, Michigan in 2012 to purchase and operate his own dental practice.

Since then, his clinical approach has focused on identifying early warning signs of oral health problems and applying treatment strategies that arrest disease progression before extensive repair becomes necessary.

The Science Behind Arrested Dental Disease
Dental research increasingly supports the idea that many oral health conditions can be stabilized when identified early.

Tooth decay, for example, is not always an unstoppable process. In its early stages, enamel demineralization can sometimes be reversed or stabilized through improved oral hygiene, fluoride exposure, dietary changes, and professional dental monitoring.

When those steps are successful, the decay may remain visible but inactive. In clinical terms, the lesion becomes arrested.

The same principle applies to gum disease. Early gum inflammation, also known as gingivitis, can often be arrested through improved oral hygiene practices and routine dental care before it progresses to periodontitis, a more severe condition that damages the bone supporting the teeth.

Dr. Howenstine believes the dental profession should talk more openly about these possibilities.

“Patients often think dentistry is only about fixing things once they break,” he says. “But many dental problems can be arrested long before they require major procedures.”

Communication as a Clinical Tool
One of the key elements of Dr. Howenstine’s practice philosophy is straightforward communication.

He believes patients make better decisions when they clearly understand their oral health status and the steps that can arrest disease progression.

“A lot of dentistry comes down to communication,” he explains. “If patients understand what early decay looks like, or what early gum inflammation means, they can take steps that help keep those problems arrested.”

This approach also emphasizes realistic treatment planning. Instead of rushing toward complex procedures, the goal is often to stabilize the condition first and monitor it over time.

Short visits, consistent monitoring, and patient education can make a significant difference.

“Small interventions done consistently can keep a lot of dental problems arrested,” Dr. Howenstine notes.

A Practical Philosophy for Modern Dentistry
Running a dental practice also requires balancing clinical care with operational discipline. Since purchasing his Stevensville practice in 2012, Dr. Howenstine has applied the same methodical approach to practice management that he applies to dentistry.

Clear documentation, structured workflows, and consistent routines help support both staff and patients.

These systems allow the practice to maintain accurate records, coordinate care effectively, and follow up on conditions that require monitoring to ensure they remain arrested.

“Consistency matters,” he says. “Whether it’s patient care or practice operations, the goal is to identify issues early and keep them from becoming larger problems.”

Beyond the Dental Chair
Dr. Howenstine’s personal interests reflect the same mindset that shapes his professional philosophy. Over the years, he has participated in varsity hockey and soccer, trained for half marathons, crewed on a racing sailboat, and competed in long-distance cross-country ski races.

These activities emphasize preparation, discipline, and endurance.

In many ways, those principles mirror the concept of arresting dental disease.

“Long-distance sports teach you that small habits repeated every day lead to better results,” he says. “The same is true for oral health.”

Regular brushing, flossing, and dental visits may seem simple, but those habits can arrest the early stages of dental disease and prevent much more complex problems later.

Rethinking the Future of Dentistry
As dental technology continues to advance, treatments will undoubtedly become more sophisticated. Yet Dr. Howenstine believes the most meaningful progress in dentistry may come from shifting the focus toward prevention and early intervention.

Rather than waiting for damage to become severe enough to require extensive procedures, dentists and patients can work together to arrest disease before it progresses.

“Dentistry doesn’t always have to be about repairing damage,” he says. “Often the best outcome is when we arrest the problem early and never let it reach that point.”

For patients, that philosophy can translate into fewer complex procedures, lower long-term costs, and healthier smiles that last for decades.

For the dental profession, it may represent a renewed focus on one of the field’s most powerful tools: prevention.

As Dr. Howenstine puts it, “If we can arrest dental disease early, we can change the entire trajectory of oral health.”

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Knot Expands into Canada, Partnering with RBC, the Country’s Largest Bank

Published

on

New York City, NY, USA, July 22nd, 2026, FinanceWire

Knot, the leading merchant connectivity platform, has announced its partnership with RBC, Canada’s largest bank, to make RBC cards the default payment method for millions of cardholders wherever they spend. Using Knot’s CardSwitcher, RBC cardholders can set their RBC card as the saved payment method at their favorite merchants directly from the RBC mobile app, without manually entering card details. The partnership marks Knot’s first expansion beyond the United States.

Keeping RBC Top of Wallet

One of the hardest moments in payments is the first one. When a cardholder gets a new RBC card, putting it to use means hunting down every merchant where a card is already saved and updating each one by hand, so a new card often sits idle for weeks before it sees real spend. The partnership removes that friction. From the RBC app, cardholders add their RBC card to their preferred merchants in a few taps and set it as the saved payment method at the places they already spend, from the day the card is in hand.

For RBC, that means a card that goes to work immediately instead of waiting to be activated across a cardholder’s everyday spend. Placing the card as the default at the merchants cardholders use most keeps it top of wallet, turning a new RBC card from an occasional choice into a go-to payment method from the start and driving repeat spend and deeper loyalty to RBC.

Expanding into Canada with the Country’s Largest Bank

For years, Knot has built the merchant connectivity layer across the United States, linking the people, financial institutions, and merchants behind everyday spend. RBC is where that infrastructure goes international for the first time. Canada is Knot’s first market beyond the U.S., and launching it with the country’s largest bank sets the standard for every market that follows.

RBC did not become Canada’s largest bank by standing still. They move early, they invest in their clients, and they push the industry forward. That is exactly the kind of partner Knot wants to build alongside, and the reason RBC is the right first step into a new market. Bringing CardSwitcher to Canadian cardholders is the start of a longer roadmap, both for what Knot and RBC build together and for where Knot goes next.

About RBC

Royal Bank of Canada is a global financial institution with a purpose-driven, principles-led approach to delivering leading performance. Its success comes from the 101,000+ employees who leverage their imaginations and insights to bring the company’s vision, values, and strategy to life so it can help its clients thrive and communities prosper. As Canada’s biggest bank, and one of the largest in the world based on market capitalization, RBC has a diversified business model with a focus on innovation and providing exceptional experiences to its more than 19 million clients in Canada, the U.S., and 27 other countries. Learn more at rbc.com.

About Knot

Knot is the leading merchant connectivity platform, simplifying how consumers, merchants, and financial institutions interact. CardSwitcher is the foundation of Knot’s product suite, letting users update and manage card-on-file payments across hundreds of merchants. Building on the same connectivity infrastructure, TransactionLink delivers SKU-level transaction data, and SubManager gives users a single place to view and manage their subscriptions. By removing friction at every step, Knot helps financial institutions grow engagement, loyalty, and spend.

Users can learn more at KnotAPI.com and connect with Knot on X (@KnotAPIs) and LinkedIn (LinkedIn.com/company/KnotAPI).

Contact

Head of Growth
Jose Del Real
Knot
press@knotapi.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

RedotPay Recognized as One of the World’s Top Fintech Companies by CNBC

Published

on

New York City, USA, July 22nd, 2026, FinanceWire

RedotPay, a global stablecoin-based payment fintech, today announced it has been named to CNBC’s World’s Top Fintech Companies 2026 list, in the Payments category. RedotPay’s inclusion in the prestigious list reflects the growth of the company, which is the global leader in stablecoin consumer payments by volume and has over eight million users.

The list is compiled independently by CNBC and Statista, based on the past year’s performance data. Now in its fourth edition, the list honors 500 companies across nine market segments — Payments, Wealth Technology, Neobanking, Alternative Financing, Digital Assets, Enterprise Fintech, Insurtech, Regtech, and Others. For each segment, performance indicators and other metrics were used to evaluate and select companies for inclusion on the list.

“We’re honored to be recognized as a leading payments fintech company by CNBC and Statista. Stablecoin-powered payments are quickly becoming trusted by millions around the world, especially among those who don’t have reliable access to traditional banking infrastructure. We remain focused on making everyday stablecoin payments accessible to many more around the world,” said Michael Gao, CEO and Co-Founder of RedotPay.

The recognition reflects RedotPay’s continued focus on making stablecoin payments accessible, reliable, and compliant for customers and businesses globally. The company recently surpassed $1bn in monthly total payment volume. Its investors include Goodwater, Galaxy, Pantera, and Lightspeed.

About RedotPay

RedotPay is a global stablecoin-based payment fintech that integrates blockchain solutions with traditional banking and finance infrastructure. Our intuitive platform empowers millions around the world to spend and send digital assets, ensuring faster, more accessible and inclusive financial services. RedotPay advances financial inclusion for the unbanked and supports crypto enthusiasts, driving global adoption of secure and flexible stablecoin-powered financial solutions to bring crypto to real life. For more information, visit www.redotpay.com.

Contact

RedotPay
press@redotpay.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

ISO-Accredited Lab Testing Exposes 86% Failure Rate in Amazon Creatine Gummies, with Over Half Containing Near-Zero Active Ingredients

Published

on

Dyad Labs Certificates of Analysis (#1406738-1 through #1462360-1) confirm widespread misbranding and dosage fraud across 15 popular e-commerce listings.

SALT LAKE CITY, Utah / LOS ANGELES, Calif. — A comprehensive market investigation evaluating 15 top-selling creatine gummy products on Amazon has uncovered systemic label fraud and active-ingredient under-dosing in the sports nutrition sector.

Analytical testing performed by Dyad Labs (A Mérieux NutriSciences Company, accredited under ISO/IEC 17025:2017) reveals that 13 out of 15 tested brands (86.7%) failed to meet their labeled claims of 5,000 mg of Creatine Monohydrate per serving.

The quantitative analysis was conducted using Method GL-604 (Determination of Creatine Monohydrate by Ultra-Performance Liquid Chromatography – UPLC), the recognized testing standard for active supplement compounds.

Shocking Laboratory Findings Across 15 Tested ASINs

According to official Certificates of Analysis (COA), 60% of tested products (9 out of 15) contained less than 1,000 mg per serving, with several extreme cases delivering less than 0.5% of the active ingredient promised on their labels:

· Near-Zero Active Creatine (<25 mg/serving):

·

Asumtal ASIN:B0F5VRJHPT/COACert#1450795-1: Tested <23.6 mg/serving (Label claim: 5,000 mg).

WELLNESS LABSRX ASIN:B0DCC4R4Q5/COACert#1450796-1: Tested <23.9 mg/serving (Label claim: 5,000 mg).

eterlower ASIN:B0FWXGC15Y/COACert#1450798-1: Tested <24.0 mg/serving (Label claim: 5,000 mg).

TASTY GAINS Collagen ASIN:B0FYPWMPZ9/COACert#1450797-1: Tested <24.0 mg/serving (Label claim: 5,000 mg).

· Severe Mislabeling & Under-Dosing (<654 mg/serving):

·

ZyterX ASIN:B0FF1R5T1Q/COACert#1406740-1: Tested <420 mg/serving.

TASTY GAINS ASIN:B0FH5J5GS4/COACert#1406739-1: Tested <454 mg/serving.

OUTELANDE ASIN:B0F4QJP5L3/COACert#1462359-1: Tested <500 mg/serving.

INNER BRIGHTNESS ASIN:B0FNBN38V4/COACert#1462360-1: Tested <500 mg/serving.

Cytona ASIN:B0F8BKD1CQ/COACert#1406747-1: Tested <654 mg/serving.

· Substantial Shortfalls (26% to 52% Deficit):

·

TASTY GAINS ASIN:B0D7N3D5X9/COACert#1406741-1: Tested 2,390 mg/serving (52% under-dosed).

Natures Aid ASIN:B0F3JBGGGZ/COACert#1406738-1: Tested 3,330 mg/serving (33% under-dosed).

Arrae ASIN:B0DX1RRWSY/COACert#1450801-1: Tested 3,410 mg/serving (32% under-dosed).

OMNI Creatine ASIN:B0F7J6DQ1V/COACert#1460718-1: Tested 3,710 mg/serving (26% under-dosed).

· Near-Compliant Top Performers:

·

Nutravita ASIN:B0CXMV6FBG/COACert#1406746-1: Tested 4,570 mg/serving.

DANEW Pro ASIN:B0DJ5HXHZS/COACert#1460717-1: Tested 4,780 mg/serving.

Master Table: Dyad Labs Analytical Certificates (ISO 17025)

Brand Name ASIN Certificate ID Testing Method Labeled Claim UPLC Result Compliance Status
Asumtal B0F5VRJHPT #1450795-1 GL-604 (UPLC) 5,000 mg <23.6 mg Severe Fraud (<0.5%)
WELLNESS LABSRX B0DCC4R4Q5 #1450796-1 GL-604 (UPLC) 5,000 mg <23.9 mg Severe Fraud (<0.5%)
TASTY GAINS B0FYPWMPZ9 #1450797-1 GL-604 (UPLC) 5,000 mg <24.0 mg Severe Fraud (<0.5%)
eterlower B0FWXGC15Y #1450798-1 GL-604 (UPLC) 5,000 mg <24.0 mg Severe Fraud (<0.5%)
ZyterX B0FF1R5T1Q #1406740-1 GL-604 (UPLC) 9,000 mg (Tot) <420 mg Severely Misbranded
TASTY GAINS B0FH5J5GS4 #1406739-1 GL-604 (UPLC) 5,000 mg <454 mg Severely Misbranded
OUTELANDE B0F4QJP5L3 #1462359-1 GL-604 (UPLC) 5,000 mg <500 mg Severely Misbranded
INNER BRIGHTNESS B0FNBN38V4 #1462360-1 GL-604 (UPLC) 5,000 mg <500 mg Severely Misbranded
Cytona B0F8BKD1CQ #1406747-1 GL-604 (UPLC) 5,000 mg <654 mg Severely Misbranded
TASTY GAINS B0D7N3D5X9 #1406741-1 GL-604 (UPLC) 5,000 mg 2,390 mg Substantial Deficit (-52%)
Natures Aid B0F3JBGGGZ #1406738-1 GL-604 (UPLC) 5,000 mg 3,330 mg Deficit (-33%)
Arrae B0DX1RRWSY #1450801-1 GL-604 (UPLC) 5,000 mg 3,410 mg Deficit (-32%)
OMNI Creatine B0F7J6DQ1V #1460718-1 GL-604 (UPLC) 5,000 mg 3,710 mg Deficit (-26%)
Nutravita B0CXMV6FBG #1406746-1 GL-604 (UPLC) 5,000 mg 4,570 mg Near-Compliant
DANEW Pro B0DJ5HXHZS #1460717-1 GL-604 (UPLC) 5,000 mg 4,780 mg Near-Compliant

Formulation Bottlenecks in Gummy Manufacturing

Food science specialists explain that Creatine Monohydrate degrades rapidly into inactive creatinine when exposed to high processing temperatures, water activity, and acidic environments—conditions intrinsic to gummy candy manufacturing. Without advanced stabilization microencapsulation, the active compound either breaks down during production or is deliberately under-dosed by manufacturers to prevent texture degradation.

Regulatory Filings and Enforcement Escalation

The complete documentation package, referencing all 15 Dyad Labs Certificates of Analysis (#1406738-1 through #1462360-1), has been submitted to:

The U.S. Food and Drug Administration (FDA) MedWatch Safety Portal

The Federal Trade Commission (FTC) Bureau of Consumer Protection

State Attorneys General Offices for investigation into deceptive marketing practices

Consumer advocacy groups are demanding that e-commerce marketplaces enforce mandatory, third-party batch verification for all gummy-form supplement listings.

Note to Editors / Media Verification:

Complete, unedited Certificates of Analysis (COA Certificate IDs #1406738-1 through #1462360-1) issued by ISO/IEC 17025 accredited Dyad Labs are officially on file and available to accredited media representatives upon request

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST